157 related articles for article (PubMed ID: 32540752)
41. Validation of the Telephone Interview of Cognitive Status and Telephone Montreal Cognitive Assessment Against Detailed Cognitive Testing and Clinical Diagnosis of Mild Cognitive Impairment After Stroke.
Zietemann V; Kopczak A; Müller C; Wollenweber FA; Dichgans M
Stroke; 2017 Nov; 48(11):2952-2957. PubMed ID: 29042492
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia.
Kanapathy A; Nik Jaafar NR; Shaharir SS; Chan LF; Rozita M; Ch'ng SS
Lupus; 2019 Jun; 28(7):854-861. PubMed ID: 31159651
[TBL] [Abstract][Full Text] [Related]
43. Association between Metabolic Syndrome and Cognitive Impairment after Acute Ischemic Stroke: A Cross-Sectional Study in a Chinese Population.
Li P; Quan W; Lu D; Wang Y; Zhang HH; Liu S; Jiang RC; Zhou YY
PLoS One; 2016; 11(12):e0167327. PubMed ID: 27936074
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic accuracy of the Montreal Cognitive Assessment (MoCA) for cognitive screening in old age psychiatry: Determining cutoff scores in clinical practice. Avoiding spectrum bias caused by healthy controls.
Dautzenberg G; Lijmer J; Beekman A
Int J Geriatr Psychiatry; 2020 Mar; 35(3):261-269. PubMed ID: 31650623
[TBL] [Abstract][Full Text] [Related]
45. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis.
Bora E; Akdede BB; Alptekin K
Psychol Med; 2017 Apr; 47(6):1030-1040. PubMed ID: 28032535
[TBL] [Abstract][Full Text] [Related]
46. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
[TBL] [Abstract][Full Text] [Related]
47. Montreal Cognitive Assessment (MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) pre-dialysis.
Paraizo Mde A; Almeida AL; Pires LA; Abrita RS; Crivellari MH; Pereira Bdos S; Fernandes NM; Bastos MG
J Bras Nefrol; 2016 Mar; 38(1):31-41. PubMed ID: 27049362
[TBL] [Abstract][Full Text] [Related]
48. Clinical features of incidental mild cognitive impairment and dementia in a population-based study.
Hishikawa N; Fukui Y; Sato K; Yamashita T; Ohta Y; Abe K
Geriatr Gerontol Int; 2017 May; 17(5):722-729. PubMed ID: 27150587
[TBL] [Abstract][Full Text] [Related]
49. Contribution of Components of Metabolic Syndrome to Cognitive Performance in Middle-Aged Adults.
Bahchevanov KM; Dzhambov AM; Chompalov KA; Massaldjieva RI; Atanassova PA; Mitkov MD
Arch Clin Neuropsychol; 2021 May; 36(4):498-506. PubMed ID: 33067992
[TBL] [Abstract][Full Text] [Related]
50. The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort.
Borland E; Nägga K; Nilsson PM; Minthon L; Nilsson ED; Palmqvist S
J Alzheimers Dis; 2017; 59(3):893-901. PubMed ID: 28697562
[TBL] [Abstract][Full Text] [Related]
51. Cognitive function and left ventricular assist device implantation.
Bhat G; Yost G; Mahoney E
J Heart Lung Transplant; 2015 Nov; 34(11):1398-405. PubMed ID: 26169667
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
[TBL] [Abstract][Full Text] [Related]
53. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
[TBL] [Abstract][Full Text] [Related]
54. Clinical value of the Montreal Cognitive Assessment (MoCA) in patients suspected of cognitive impairment in old age psychiatry. Using the MoCA for triaging to a memory clinic.
Dautzenberg G; Lijmer J; Beekman A
Cogn Neuropsychiatry; 2021 Jan; 26(1):1-17. PubMed ID: 33272076
[No Abstract] [Full Text] [Related]
55. Changes in Montreal Cognitive Assessment Scores Over Time.
Krishnan K; Rossetti H; Hynan LS; Carter K; Falkowski J; Lacritz L; Cullum CM; Weiner M
Assessment; 2017 Sep; 24(6):772-777. PubMed ID: 27318033
[TBL] [Abstract][Full Text] [Related]
56. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
[TBL] [Abstract][Full Text] [Related]
57. Effects of Metabolic Syndrome on Cognitive Impairment with White Matter Lesions.
Chen L; Hong W; Yang H; Dong S; Peng Z; Zhou H
Eur Neurol; 2019; 82(4-6):99-105. PubMed ID: 31865320
[TBL] [Abstract][Full Text] [Related]
58. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging.
Solfrizzi V; Scafato E; Capurso C; D'Introno A; Colacicco AM; Frisardi V; Vendemiale G; Baldereschi M; Crepaldi G; Di Carlo A; Galluzzo L; Gandin C; Inzitari D; Maggi S; Capurso A; Panza F;
Neurobiol Aging; 2011 Nov; 32(11):1932-41. PubMed ID: 20045217
[TBL] [Abstract][Full Text] [Related]
59. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
[TBL] [Abstract][Full Text] [Related]
60. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
